Evidence map›Paper›PMID 33498667›Full record

ReviewNutrients2021

Curcumin from Turmeric Rhizome: A Potential Modulator of DNA Methylation Machinery in Breast Cancer Inhibition.

Krystyna Fabianowska-Majewska, Agnieszka Kaufman-Szymczyk, Aldona Szymanska-Kolba, Jagoda Jakubik, Grzegorz Majewski, Katarzyna Lubecka

Open access · goldAbstract readReview
In one paragraph

Review in Nutrients, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
3.2field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 59 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Review
  10. Review
  11. Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Krystyna Fabianowska-MajewskaFaculty of Medicine, Lazarski University, 02-662 Warsaw, Poland.
Agnieszka Kaufman-SzymczykDepartment of Biomedical Chemistry, Faculty of Health Sciences, Medical University of Lodz, 92-215 Lodz, Poland.ORCID 0000-0001-6014-7280
Aldona Szymanska-KolbaDepartment of Biomedical Chemistry, Faculty of Health Sciences, Medical University of Lodz, 92-215 Lodz, Poland.
Jagoda JakubikDepartment of Biomedical Chemistry, Faculty of Health Sciences, Medical University of Lodz, 92-215 Lodz, Poland.
Grzegorz MajewskiFaculty of Medicine, Lazarski University, 02-662 Warsaw, Poland.
Katarzyna LubeckaDepartment of Biomedical Chemistry, Faculty of Health Sciences, Medical University of Lodz, 92-215 Lodz, Poland.ORCID 0000-0002-4250-0922
Medical University of Lodz · PLUczelnia Łazarskiego · PL

Funding

Medical University of Lodz, Lodz, Poland 503/6-099-01/503-61-001-19-00
6 · The paper itself

Abstract

One of the most systematically studied bioactive nutraceuticals for its benefits in the management of various diseases is the turmeric-derived compounds: curcumin. Turmeric obtained from the rhizome of a perennial herb

Indexed as

Breast NeoplasmsCurcumaCurcuminDNA MethylationEpigenomicsFemaleGene Expression Regulation, NeoplasticHumansRhizomeCurcuminbioactive nutraceuticalbreast cancerchemopreventioncurcuminDNA methylationnutriepigenomicsturmeric

Identifiers

PMID33498667
PMCPMC7910847
OpenAlexW3125060758

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.